The risk of respiratory tract infections and interstitial lung disease with interleukin 12/23 and interleukin 23 antagonists in patients with autoimmune diseases: A systematic review and meta-analysis
Shintaro Akiyama, Akihiro Yamada, Dejan Micić, Atsushi Sakuraba
Topics & Concepts
MedicineRespiratory tract infectionsInternal medicinePlaceboPneumoniaRelative riskInterstitial lung diseaseMeta-analysisRandomized controlled trialRisk factorImmunologyLungConfidence intervalRespiratory systemPathologyAlternative medicinePsoriasis: Treatment and PathogenesisChronic Obstructive Pulmonary Disease (COPD) ResearchInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis